Ischemic Colitis occurs when blood flow to part of the colon is reduced or blocked, causing inflammation and potential tissue damage. Symptoms can range from mild abdominal discomfort to severe ...

Ulcerative Colitis (UC) is a chronic inflammatory bowel disease affecting the colon lining, and its incidence is rising globally, especially in industrialized countries. The causes of UC are ...

Renfrow spent the 2024 season dealing with complications from an ulcerative colitis diagnosis. The autoimmune disease left the 29-year-old feeling lethargic as he battled high fevers and ...

Artificial intelligence (AI) is used in ulcerative colitis to assist in the assessment, monitoring, and management of disease. To explain how this technology is being applied in the clinical ...

Talk to your doctor about whether you meet the criteria. What is the main cause of ulcerative colitis? The exact cause of ulcerative colitis is unknown, but it is believed to involve a combination ...

Have you ever found yourself in a situation where, despite your best efforts, your Ulcerative Colitis (UC) symptoms flare up unexpectedly? UC, a chronic inflammatory bowel disease, can be ...

Ulcerative colitis happens when the immune system goes out of control and causes inflammation that can lead to tissue damage in the colon and rectum. Image Credit: iStock/Getty Images There’s no ...

Living with ulcerative colitis (UC) requires taking good care of your physical health. Taking your medication and avoiding foods that worsen symptoms can bring relief from diarrhea and abdominal ...

Johnson & Johnson (J&J) has announced that its dual-acting IL-23 inhibitor Tremfya (guselkumab) has been approved by the European Commission (EC) to treat adults with ulcerative colitis (UC). Patients ...

French biotech moves on with the late stage drug development, after publishing impressive clinical trial results of ABX464 for treatment of colitis and hinting its potential in Crohn’s disease.